A novel nonsense mutation (G181X) in the human cholesteryl ester transfer protein gene in Japanese hyperalphalipoproteinemic subjects

Journal of Lipid Research

Volumn 37, Issue 10, 1996, Pages 2145-2154

  Arai, Takeshi ^a   Yamashita, Shizuya ^a   Sakai, Naohiko ^a   Hirano, Ken Ichi ^a   Okada, Sugako ^a   Ishigami, Masato ^a   Maruyama, Takao ^a   Yamane, Mitsukazu ^a   Kobayashi, Hitoshi ^a   Nozaki, Shuichi ^a   Funahashi, Tohru ^a   Kameda Takemura, Kaoru ^a   Nakajima, Norimichi ^b   Matsuzawa, Yuji ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b Nakajima Clinic   (Japan)

Author keywords

atherosclerosis; cholesteryl ester transfer protein deficiency; high density lipoprotein; mutation; reverse cholesterol transport

Indexed keywords

CHOLESTEROL; CHOLESTEROL ESTER TRANSFER PROTEIN; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; GENE MUTATION; GENETIC DISORDER; HUMAN; HYPERLIPOPROTEINEMIA; LIPID BLOOD LEVEL; LIPOPROTEIN METABOLISM; MAJOR CLINICAL STUDY; MALE; MUTATION RATE; NUCLEIC ACID BASE SUBSTITUTION; PEDIGREE; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

CARRIER PROTEINS; CHOLESTEROL ESTER TRANSFER PROTEINS; CHOLESTEROL, HDL; CODON; DEOXYRIBONUCLEASES, TYPE II SITE-SPECIFIC; DNA; FEMALE; GLYCINE; GLYCOPROTEINS; HUMANS; HYPERLIPOPROTEINEMIAS; JAPAN; MIDDLE AGED; MUTATION; PEDIGREE; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH;

EID: 10244232759     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Groener, J. E. M., A. J. Van Rosen, and D. W. Erkelens. 1984. Cholesteryl ester transfer activity; localization and role in distribution of cholesteryl ester among lipoproteins in man. Atherosclerosis. 50: 261-271.
2. Yamashita, S., D. Y. Hui, J. R. Wetterau, D. L. Sprecher, J. A. K. Harmony, Y. Matsuzawa, and S. Tarui. 1991. Characterization of plasma lipoproteins in patients heterozygous for human plasma cholesteryl ester transfer protein (CETP) deficiency. Plasma CETP regulates high density lipoprotein concentration and composition. Metabolism. 40: 756-763.
3. Brown, M. L., A. Inazu, C. B. Hesler, L. B. Agellon, C. Mann, M. E. Whitlock, Y. L. Marcel, R. W. Milne, J. Koizumi, H. Mabuchi, R. Takeda, and A. R. Tall. 1989. Molecular basis of lipid transfer protein deficiency in a family with increased high density lipoproteins. Nature. 342: 448-451.
4. Inazu, A., M. L. Brown, C. B. Hesler, L. B. Agellon, J. Koizumi, K. Takara, Y. Maruhama, H. Mabuchi, and A. R. Tall. 1990. Increased high density lipoprotein levels caused by a common cholesteryl ester transfer protein gene mutation. N. Engl. J. Med. 323: 1234-1238.
5. Inazu, A., X. C. Jiang, T. Haraki, K. Yagi, N. Kamon, J. Koizumi, H. Mabuchi, R. Takeda, K. Takara, Y. Moriyama, M. Doi, and A. R. Tall. 1994. Genetic cholesteryl ester transfer protein deficiency caused by two prevalent mutations as a major determinant of increased levels of high density lipoprotein cholesterol. J. Clin. Invest. 94: 1872-1882.
6. Yamashita, S., Y. Matsuzawa, M. Okazaki, H. Kako, T. Yasugi, H. Akioka, K. Hirano, and S. Tarui. 1988. Small polydisperse low density lipoproteins in familial hyperalphalipoproteinemia with complete deficiency of cholesteryl ester transfer activity. Atherosclerosis. 70: 7-12.
7. Sakai, N., Y. Matsuzawa, K. Hirano, S. Yamashita, S. Nozaki, Y. Ueyama, M. Kubo, and S. Tarui. 1991. Detection of two species of low density lipoprotein particles in cholesteryl ester transfer protein deficiency. Arterioscler. Thromb. 11: 71-79.
8. Hirano, K., S. Yamashita, T. Funahashi, N. Sakai, M. Menju, M. Ishigami, H. Hiraoka, T. Kameda-Takemura, K. Tokunaga, T. Hoshino, K. Kumasaka, and Y. Matsuzawa. 1993. Frequency of intron 14 splicing defect of cholesteryl ester transfer protein gene in the Japanese general population-relation between the mutation and hyperalphalipoproteinemia. Atherosclerosis. 100: 85-90.
9. Yamashita, S., D. L. Sprecher, N. Sakai, Y. Matsuzawa, S. Tarui, and D. Y. Hui. 1990. Accumulation of apolipoprotein E-rich high density lipoproteins in hyperalphalipoproteinemic human subjects with plasma cholesteryl ester transfer protein deficiency. J. Clin. Invest. 86: 688-695.
10. 2-cholesterolemia with abnormal cholesteryl ester transfer. Am. J. Cardiol. 62: 66B-72B.
11. Reich, D., and N. E. Miller. 1989. Pathophysiology of reverse cholesterol transport. Insight from inherited disorders of lipoprotein metabolism. Arteriosclerosis. 9: 785-797.
12. Tall, A. R. 1993. Plasma cholesteryl ester transfer protein. J. Lipid Res. 34: 1255-1274.
13. Sakai, N., S. Yamashita, K. Hirano, M. Menju, T. Arai, K. Kobayashi, M. Ishigami, Y. Yoshida, T. Hoshino, N. Nakajima, K. Kameda-Takemura, and Y. Matsuzawa. 1995. Frequency of exon 15 missense mutation (442 D:G) in cholesteryl ester transfer protein gene in hyperalphalipoproteinemic Japanese subjects. Atherosclerosis. 114: 139-145.
14. Havel, R. J., H. A. Eder, and J. H. Bragdon. 1955. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J. Clin. Invest. 34: 1345-1353.
15. Burstein, M., and H. R. Scholnick. 1973. Lipoprotein-polyanion-metal interaction. Adv. Lipid Res. 11: 67-108.
16. Goto, Y., Y. Akanuma, Y. Harano, Y. Hata, H. Itakura, G. Kajiyama, M. Kawade, S. Koga, F. Kuzuya, Y. Maruhama, Y. Matsuzawa, A. Murai, T. Murase, C. Naito, T. Nakai, A. Noma, Y. Saito, J. Sasaki, N. Takeuchi, H. Tamachi, H. Uzawa, A. Yamamoto, S. Yamazaki, T. Yasugi, and S. Yukawa. 1986. Determination by the SRID method of normal value of serum apolipoproteins (A-I, A-II, B, C-Il, C-III and E) in normolipidemic healthy subjects. J. Clin. Biochem. Nutr. 1: 73-88.
17. Lowry, O. H., N. J. Rosebrough, A. L. Farr, and R. J. Randall. 1951. Protein measurement with the Folin phenol reagent. J Biol. Chem. 193: 265-275.
18. Nichols, A. V., R. M. Krauss, and T. A. Musliner. 1986. Nondenaturing polyacrylamide gradient gel electrophoresis. Methods Enzymol. 8: 417-431.
19. Kato, H., T. Nakanishi, H. Arai, H. Nishida, and T. Nishida. 1989. Purification, microheterogeneity, and stability of human lipid transfer protein. J Biol. Chem. 264: 4082-4087.
20. Sato, T., M. Fukasawa, M. Kinoshita, H. Arai, T. Saeki, T. Naraki, Y. Iwasaki, T. Teramoto, K. Takahashi, Y. Saito, and K. Inoue. 1995. Enzyme-linked immunosorbent assay for cholesteryl ester transfer protein in human serum. Clin. Chim. Acta. 240: 1-9.
21. Kunkel, L. M., K. D. Smith, S. H. Boyer, D. S. Borgaonkar, S. S. Wachtel, O. J. Miller, W. R. Breg, H. W. Jones, and J. M. Rary. 1977. Analysis of human Y-chromosome-specific reiterated DNA in chromosome variants. Proc. Natl. Acad. Sci. USA. 74: 1245-1249.
22. Yamashita, S., D. Y. Hui, D. L. Sprecher, Y. Matsuzawa, N. Sakai, S. Tarui, D. Kaplan, J. R. Wetterau, and J. A. K. Harmony. 1990. Total deficiency of plasma cholesteryl ester transfer protein in subjects homozygous and heterozygous for the intron 14 splicing defect. Biochim. Biophys. Res. Commun. 170: 1346-1351.
23. Takahashi, K., X. C. Jiang, N. Sakai, S. Yamashita, K. Hirano, H. Bujo, H. Yamazaki, J. Kusunoki, T. Miura, P. Russie, Y. Matsuzawa, Y. Saito, and A. R. Tall. 1993. A missense mutation in the cholesteryl ester transfer protein gene with possible dominant effects on plasma high density lipoproteins. J. Clin. Invest. 92: 2060-2064.
24. Gotoda, T., M. Kinoshita, H. Shimano, K. Harada, M. Shimada, J. Ohsuga, T. Teramoto, Y. Yazaki, and N. Yamada. 1993. Cholesteryl ester transfer protein deficiency caused by a nonsense mutation detected in the patient's macrophage mRNA. Biochem. Biophys. Res. Commun. 194: 519-524.
25. Funke, H., H. Wiebusch, L. Fuer, S. Muntoni, H. Schulte, and G. Assmann. 1994. Identification of mutations in the cholesterol ester transfer protein in Europeans with elevated high density lipoprotein cholesterol. Circulation. (Suppl.) 90:1-241 (abstract).
26. Marotti, R. K., C. K. Castle, T. P. Boyle, A. H. Lin, R. W. Murray, and G. W. Melchior. 1993. Severe atherosclerosis in transgenic mice expressing simian cholesteryl ester transfer protein. Nature. 364: 73-75.
27. Ishigami, M., S. Yamashita, N. Sakai, T. Arai, K. Hirano, H. Hiraoka, K. Kameda-Takemura, and Y. Matsuzawa. 1994. Large and cholesteryl ester-rich high density lipoproteins in cholesteryl ester transfer protein (CETP) deficiency can not protect macrophages from cholesterol accumulation induced by acetylated low-density lipoproteins. J. Biochem. 116: 257-262.
28. Sakai, N., S. Yamashita, K. Hirano, M. Ishigami, T. Arai, K. Kobayashi, T. Funahashi, and Y. Matsuzawa. 1995. Decreased affinity of low density lipoprotein (LDL) particles to LDL receptors in patients with cholesteryl ester transfer protein deficiency. Eur. J. Clin. Invest. 25: 332-339.
29. 2-cholesterolemia associated with premature corneal opacity - a case report. Atherosclerosis. 53: 207-212.
30. Hirano, K., S. Yamashita, N. Sakai, T. Arai, Y. Yoshida, S. Nozaki, K. Kameda-Takemura, and Y. Matsuzawa. 1995. Molecular defect and atherogenicity in cholesteryl ester transfer protein deficiency. Ann. NY Acad. Sci. 748: 599-602.
31. Hirano, K., S. Yamashita, Y. Kuga, N. Sakai, S. Nozaki, S. Kihara, T. Arai, K. Yanagi, S. Takami, M. Menju, M. Ishigami, Y. Yoshida, K. Kameda-Takemura, K. Hayashi, and Y. Matsuzawa. 1995. Atherosclerotic disease in marked hyperalphalipoproteinemia - combined reduction of cholesteryl ester transfer protein and hepatic triglyceride lipase. Arterioscler. Thromb. Vasc. Biol. 15: 1849-1856.
32. Yamashita, S., M. Ishigami, T. Ara, N. Sakai, K. Hiran, K. Kameda-Takemura, K. Tokunaga, and Y. Matsuzawa. 1995. Very high density lipoproteins induced by plasma cholesteryl ester transfer protein (CETP) have a potent antiatherogenic function. Ann. NY Acad. Sci. 748: 606-608.
33. Franceschini, G., G. Chiesa, and C. R. Sirtori. 1991. Probucol increases cholesteryl ester transfer protein activity in hypercholesterolemic patients. Eur. J. Clin. Invest. 21: 384-388.
34. Hayek, T., M. L. Masucci, X. Jiang, A. Walsh, E. Rubin, J. L. Breslow, and A. R. Tall. 1995. Decreased early atherosclerotic lesions in hypertriglyceridemic mice expressing cholesteryl ester transfer protein transgene. J. Clin. Invest. 96: 2071-2074.